甲胺毒性:DPYD的隐藏秘密
Vangelis G Manolopoulos1,2,3, Georgia Ragia1,2
1Laboratory of Pharmacology, Medical School, Democritus University of Thrace, Dragana Campus, Alexandroupolis, 68100, Greece.
Current drug metabolism
|March 20, 2024
概括
DPYD基因变异是胺毒性的关键,但其他因素也会影响二胺脱酶 (DPD) 活性. 了解这些额外的机制对于提高癌症治疗安全性至关重要.
科学领域:
- 药物基因组学 药物基因组学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 烯胺类药物治疗受到毒性限制.
- DPYD基因多态度通过影响二皮里米丁脱酶 (DPD) 酶活性来预测毒性.
- DPYD的变化不能完全解释观察到的胺毒性.
研究的目的:
- 审查其他导致DPD酶活性变化的因素.
- 探索影响DPD的表观遗传调节,蛋白质修饰和药物酶相互作用.
- 为了了解胺毒性DPD变异的全谱.
主要方法:
- 对表观遗传调节 (DNA甲基化,非编码RNAs) 的文献综述.
- 对翻译后蛋白质修饰和环境因素的分析.
- 药物酶相互作用的检查,包括案例研究.
主要成果:
- DPYD促进物甲基化对毒性的临床影响尚不清楚.
- 非编码RNAs (miRNA,piRNA,circRNA,lncRNA) 在转录后调节DPYD.
- DPD蛋白质的修饰,环境因素和药物相互作用 (例如,索里武丁) 都会导致毒性.
结论:
- DPYD多态是DPD变化的主要来源.
- 对DPYD的表观遗传调节提供了对毒性机制的见解.
- 翻译后的修改和DPD的药物抑制需要进一步的研究,以获得更安全的甲胺使用.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
134
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
134


